169 related articles for article (PubMed ID: 16113842)
1. Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.
Messmer D; Telusma G; Wasil T; Messmer BT; Allen S; Rai KR; Chiorazzi N
Mol Med; 2004; 10(7-12):96-103. PubMed ID: 16113842
[TBL] [Abstract][Full Text] [Related]
2. Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia.
Lee JJ; Foon KA; Mailliard RB; Muthuswamy R; Kalinski P
J Leukoc Biol; 2008 Jul; 84(1):319-25. PubMed ID: 18426971
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
Rezvany MR; Jeddi-Tehrani M; Biberfeld P; Söderlund J; Mellstedt H; Osterborg A; Rabbani H
Br J Haematol; 2001 Nov; 115(2):263-71. PubMed ID: 11703320
[TBL] [Abstract][Full Text] [Related]
4. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
[TBL] [Abstract][Full Text] [Related]
5. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
6. Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia.
Vuillier F; Maloum K; Thomas EK; Jouanne C; Dighiero G; Scott-Algara D
Br J Haematol; 2001 Dec; 115(4):831-44. PubMed ID: 11843817
[TBL] [Abstract][Full Text] [Related]
7. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
8. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
Orsini E; Pasquale A; Maggio R; Calabrese E; Mauro FR; Giammartini E; Guarini A; Foa R
Br J Haematol; 2004 Jun; 125(6):720-8. PubMed ID: 15180861
[TBL] [Abstract][Full Text] [Related]
11. Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells.
Oppezzo P; Magnac C; Bianchi S; Vuillier F; Tiscornia A; Dumas G; Payelle-Brogard B; Ajchenbaum-Cymbalista F; Dighiero G; Pritsch O
Leukemia; 2002 Dec; 16(12):2438-46. PubMed ID: 12454750
[TBL] [Abstract][Full Text] [Related]
12. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
[TBL] [Abstract][Full Text] [Related]
13. GIFT4 fusokine converts leukemic B cells into immune helper cells.
Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J
J Transl Med; 2016 Apr; 14(1):106. PubMed ID: 27118475
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
15. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells.
Müller MR; Tsakou G; Grünebach F; Schmidt SM; Brossart P
Blood; 2004 Mar; 103(5):1763-9. PubMed ID: 14615377
[TBL] [Abstract][Full Text] [Related]
16. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
Johnson TA; Rassenti LZ; Kipps TJ
J Immunol; 1997 Jan; 158(1):235-46. PubMed ID: 8977195
[TBL] [Abstract][Full Text] [Related]
17. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
18. Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
Ghiotto F; Fais F; Albesiano E; Sison C; Valetto A; Gaidano G; Reinhardt J; Kolitz JE; Rai K; Allen SL; Ferrarini M; Chiorazzi N
Mol Med; 2006; 12(11-12):300-8. PubMed ID: 17380195
[TBL] [Abstract][Full Text] [Related]
19. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
Damle RN; Wasil T; Fais F; Ghiotto F; Valetto A; Allen SL; Buchbinder A; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Vinciguerra VP; Rai KR; Ferrarini M; Chiorazzi N
Blood; 1999 Sep; 94(6):1840-7. PubMed ID: 10477712
[TBL] [Abstract][Full Text] [Related]
20. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]